Gary Hao, Ph.D.

Gary Hao has 17 years of experience in CMC development from discovery through commercialization. Prior to joining Vesigen, he served as Vice President of Analytical and Formulation Development at Codiak BioSciences, where he oversaw the CMC activities of three clinical-stage extracellular vesicle programs. Before Codiak, Gary worked at companies including Merck KGaA and TG therapeutics, where he co-invented BAVENCIO and filed BLA for BRIUMVI, respectively. Gary obtained his B.S. degree in biochemistry from Nankai University and Ph.D. degree in pharmacology from Cornell University.